This study was designed to determine if Probudur reduces pain behaviors in a rat model of incisional pain. Probudur is being developed by Virpax to significantly reduce or eliminate the need for opioids after surgery or trauma in approved indications. In pre-clinical trials, Probudur has shown long duration pain control for at least 96 hours. About Virpax PharmaceuticalsVirpax is developing branded, non-addictive pain management products candidates using its proprietary technologies to optimize and target drug delivery. Virpax is initially seeking FDA approval for two prescription drug candidates that employ two different patented drug delivery platforms.

Source: Forbes February 07, 2024 12:54 UTC